Nine Researchers Honored for Outstanding Achievements at AACC Meeting
|
By LabMedica International staff writers Posted on 20 Jul 2012 |
AACC 2012: American Association for Clinical Chemistry (AACC; Washington DC, USA) President Greg Miller, PhD, presented nine awards at the 2012 annual meeting in Los Angeles (CA, USA).
Eric D. Green, MD, PhD received the Wallace H. Coulter Lectureship Award, which recognizes an individual whose efforts have had a profound effect on the field of clinical chemistry. He is director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) in Bethesda (MD, USA), where he is chief of its technology branch, and director of the NIH Intramural Sequencing Center.
Dr. Green has led efforts to map, sequence, and understand eukaryotic genomes. He provided important insights about genome structure, function, and evolution.
Thomas P. Moyer, PhD, received the Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine. Dr. Moyer is professor of laboratory medicine and pathology, clinical laboratory director, and senior vice president of Mayo Medical Laboratories Rochester (MN, USA). He created and directed the drug laboratory there, and has developed more than 120 diagnostic test procedures.
The AACC Award for Outstanding Contributions through Service to the Profession of Clinical Chemistry was presented to John E. Sherwin, PhD. Dr. Sherwin recently retired from his position as director of laboratory operations for Perkin Elmer Life and Analytical Sciences in (Waltham, MA, USA), where he was responsible for the genetic screening and neural tube defects laboratories.
David B. Sacks, MB, ChB won the AACC Award for Outstanding Contributions in Education. He is senior investigator, chief of the clinical chemistry service, and deputy chief of the department of laboratory medicine at the National Institutes of Health in Bethesda.
In his previous positions as associate professor of pathology at Harvard Medical School (Boston, MA, USA) and medical director of clinical chemistry at the Brigham and Women’s Hospital in Boston (MA, USA), he established and directed a residency training program in clinical pathology. During the 20 years he directed the program more than 50 residents were recruited who have become successful physician-scientists and leaders in health care.
Dr Sacks' scientific work is in the area of intracellular signal transduction, with a focus on calcium and calmodulin signaling. His primary clinical interest is in diabetes mellitus, with an emphasis on the interface between the clinical laboratory and patient care.
Yuk-Ming Dennis Lo, MD accepted the Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, which is cosponsored by the National Academy of Clinical Biochemistry, for his paradigm-changing work in prenatal diagnostics. Dr. Lo is the director of the Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong (China) and chair of the department of chemical pathology of the same institute.
Dr. Lo and colleagues made the discovery that the DNA of the fetus can be found in the plasma of the pregnant mother. This discovery challenged the conventional wisdom that the placenta serves as a barrier between the fetal and maternal blood, and opened new possibilities for noninvasive prenatal diagnosis. Subsequently Dr. Lo elucidated the fundamental biological characteristics of the fetal DNA in the mother’s bloodstream and demonstrated that it can be used for the prenatal diagnosis of diseases and for blood group genotyping.
Dr Lo developed an approach based on molecular counting and genetic sequencing to detect fetal chromosome abnormalities. He, together with his team published the first large-scale validation of this technology for Down syndrome detection, and the technology was introduced into clinical practice. Recently, Dr. Lo demonstrated that a genetic map of the fetus could be deduced by sequencing of the pregnant mother’s plasma. His work has made prenatal testing safer for the fetus and less stressful for the mother.
The Award for Scientific Achievements by a Young Investigator went to Andy Hoofnagle, MD, PhD, assistant professor in the department of laboratory medicine at the University of Washington (Seattle). He also serves as the director of clinical mass spectrometry, director of reference lab services, and assistant director of the clinical chemistry and clinical immunology laboratories.
Dr. Hoofnagle's laboratory has helped pioneer the clinical use of immunoaffinity peptide enrichment to quantify low-abundance proteins in complex mixtures. His team has also demonstrated the potential for bottom-up proteomics approaches in the quantification of proteins in the clinical laboratory. His laboratory has developed high-throughput assays for vitamin D metabolites that have been used in population studies to quantify the cardiovascular risk associated with low vitamin D levels.
Hans Lilja, MD, PhD received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics. Dr. Lilja is an attending research clinical chemist in the department of laboratory medicine at Memorial Sloan-Kettering Cancer Center (New York, NY, USA), an adjunct professor in the department of laboratory medicine at Lund University (Malmö, Sweden), and a Finland Distinguished Professor at the University of Tampere (Finland).
Dr. Lilja’s discoveries involving prostate-specific antigen (PSA) led to widespread use of the PSA test as a marker for prostate cancer. His current research focuses on biomarker discovery, assay development, and clinical validation of biomarkers in population-based cohorts. His research has refined the association between PSA levels and prognosis, and identified additional markers, including a panel that can help to determine which men should have a prostate biopsy.
The Helen Free Travel Award provides financial assistance to allow a nondoctoral-level AACC member to attend an AACC meeting. The winner was Sue Lam, who is a medical technologist in the molecular diagnostics laboratory of the hospital at the University of Medicine and Dentistry of New Jersey (Newark, NJ, USA).
She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virologic response of inner-city patients infected with Hepatitis C virus. Ms. Lam’s expertise includes a wide range of clinical laboratory technologies including several molecular diagnostics measurement procedures. She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virological response of inner-city patients infected with Hepatitis C virus.
The AACC Past President’s Award was presented to Ann M. Gronowski, PhD a professor in the department of pathology and immunology and the department of obstetrics and gynecology at the Washington University School of Medicine in St. Louis (MO, USA). She is associate medical director of the clinical chemistry, serology, and immunology laboratories at Barnes-Jewish Hospital (St. Louis, MO, USA).
The AACC’s consumer-oriented website Lab Tests Online celebrated its 10th anniversary and the 100 millionth visitor by continuing to expand its national and international reach. The site now meets the needs of 2 million visitors a month, with 15 international sites in 12 languages.
Awards were sponsored by the Wallace H. Coulter Foundation, Abbott Diagnostics, BD Diagnostics – Preanalytical Systems, Beckman Coulter, Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics.
Related Links:
AACC
Eric D. Green, MD, PhD received the Wallace H. Coulter Lectureship Award, which recognizes an individual whose efforts have had a profound effect on the field of clinical chemistry. He is director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) in Bethesda (MD, USA), where he is chief of its technology branch, and director of the NIH Intramural Sequencing Center.
Dr. Green has led efforts to map, sequence, and understand eukaryotic genomes. He provided important insights about genome structure, function, and evolution.
Thomas P. Moyer, PhD, received the Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine. Dr. Moyer is professor of laboratory medicine and pathology, clinical laboratory director, and senior vice president of Mayo Medical Laboratories Rochester (MN, USA). He created and directed the drug laboratory there, and has developed more than 120 diagnostic test procedures.
The AACC Award for Outstanding Contributions through Service to the Profession of Clinical Chemistry was presented to John E. Sherwin, PhD. Dr. Sherwin recently retired from his position as director of laboratory operations for Perkin Elmer Life and Analytical Sciences in (Waltham, MA, USA), where he was responsible for the genetic screening and neural tube defects laboratories.
David B. Sacks, MB, ChB won the AACC Award for Outstanding Contributions in Education. He is senior investigator, chief of the clinical chemistry service, and deputy chief of the department of laboratory medicine at the National Institutes of Health in Bethesda.
In his previous positions as associate professor of pathology at Harvard Medical School (Boston, MA, USA) and medical director of clinical chemistry at the Brigham and Women’s Hospital in Boston (MA, USA), he established and directed a residency training program in clinical pathology. During the 20 years he directed the program more than 50 residents were recruited who have become successful physician-scientists and leaders in health care.
Dr Sacks' scientific work is in the area of intracellular signal transduction, with a focus on calcium and calmodulin signaling. His primary clinical interest is in diabetes mellitus, with an emphasis on the interface between the clinical laboratory and patient care.
Yuk-Ming Dennis Lo, MD accepted the Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, which is cosponsored by the National Academy of Clinical Biochemistry, for his paradigm-changing work in prenatal diagnostics. Dr. Lo is the director of the Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong (China) and chair of the department of chemical pathology of the same institute.
Dr. Lo and colleagues made the discovery that the DNA of the fetus can be found in the plasma of the pregnant mother. This discovery challenged the conventional wisdom that the placenta serves as a barrier between the fetal and maternal blood, and opened new possibilities for noninvasive prenatal diagnosis. Subsequently Dr. Lo elucidated the fundamental biological characteristics of the fetal DNA in the mother’s bloodstream and demonstrated that it can be used for the prenatal diagnosis of diseases and for blood group genotyping.
Dr Lo developed an approach based on molecular counting and genetic sequencing to detect fetal chromosome abnormalities. He, together with his team published the first large-scale validation of this technology for Down syndrome detection, and the technology was introduced into clinical practice. Recently, Dr. Lo demonstrated that a genetic map of the fetus could be deduced by sequencing of the pregnant mother’s plasma. His work has made prenatal testing safer for the fetus and less stressful for the mother.
The Award for Scientific Achievements by a Young Investigator went to Andy Hoofnagle, MD, PhD, assistant professor in the department of laboratory medicine at the University of Washington (Seattle). He also serves as the director of clinical mass spectrometry, director of reference lab services, and assistant director of the clinical chemistry and clinical immunology laboratories.
Dr. Hoofnagle's laboratory has helped pioneer the clinical use of immunoaffinity peptide enrichment to quantify low-abundance proteins in complex mixtures. His team has also demonstrated the potential for bottom-up proteomics approaches in the quantification of proteins in the clinical laboratory. His laboratory has developed high-throughput assays for vitamin D metabolites that have been used in population studies to quantify the cardiovascular risk associated with low vitamin D levels.
Hans Lilja, MD, PhD received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics. Dr. Lilja is an attending research clinical chemist in the department of laboratory medicine at Memorial Sloan-Kettering Cancer Center (New York, NY, USA), an adjunct professor in the department of laboratory medicine at Lund University (Malmö, Sweden), and a Finland Distinguished Professor at the University of Tampere (Finland).
Dr. Lilja’s discoveries involving prostate-specific antigen (PSA) led to widespread use of the PSA test as a marker for prostate cancer. His current research focuses on biomarker discovery, assay development, and clinical validation of biomarkers in population-based cohorts. His research has refined the association between PSA levels and prognosis, and identified additional markers, including a panel that can help to determine which men should have a prostate biopsy.
The Helen Free Travel Award provides financial assistance to allow a nondoctoral-level AACC member to attend an AACC meeting. The winner was Sue Lam, who is a medical technologist in the molecular diagnostics laboratory of the hospital at the University of Medicine and Dentistry of New Jersey (Newark, NJ, USA).
She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virologic response of inner-city patients infected with Hepatitis C virus. Ms. Lam’s expertise includes a wide range of clinical laboratory technologies including several molecular diagnostics measurement procedures. She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virological response of inner-city patients infected with Hepatitis C virus.
The AACC Past President’s Award was presented to Ann M. Gronowski, PhD a professor in the department of pathology and immunology and the department of obstetrics and gynecology at the Washington University School of Medicine in St. Louis (MO, USA). She is associate medical director of the clinical chemistry, serology, and immunology laboratories at Barnes-Jewish Hospital (St. Louis, MO, USA).
The AACC’s consumer-oriented website Lab Tests Online celebrated its 10th anniversary and the 100 millionth visitor by continuing to expand its national and international reach. The site now meets the needs of 2 million visitors a month, with 15 international sites in 12 languages.
Awards were sponsored by the Wallace H. Coulter Foundation, Abbott Diagnostics, BD Diagnostics – Preanalytical Systems, Beckman Coulter, Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics.
Related Links:
AACC
Latest 2012 AACC News
- South Korea to Educate Patients About Lab Tests
- Laboratory Testing Platform for Vitamin D Assay Validated
- Mobile Blood Gas Analyzer for Hospital POC Launched
- Next Generation Automation Solution Exhibited at AACC
- Extended Range HRP Microwell Substrate Launched
- Automated, Compact, Random Access Chemistry Analyzer Featured at AACC
- IVD Market Exceeded USD 50 Billion in 2011
- Hematology Analyzers Offer Channel for Immature Platelet Fraction
- New Solutions for Health Labs Featured at Expo
- Assistant Cell Image Analyzer for Hematology Labs Released
- Blood Test Detects Patients at Risk for Diabetes
- Efficiency and Workflow Enhanced in Today’s Laboratories
- Web-Based Software Platform Manages Lab Information
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








